BURRELL INTERNATIONAL GROUP LLC for EMERGENT BIOSOLUTIONS INC (F/K/A ADAPT PHARMA INC )
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 6, Labor HHS Appropriations; CARA 2.0; POWER Act; Naloxone access provisions, generally; Opioid Package, issues relating to: naloxone access, coprescribing/opioid prescribing guidelines, Judiciary, Appropriations, Energy and Commerce, and Senate HELP provisions, generally.
Foreign entity interest: Adapt Pharma is a U.S. domestic subsidiary of a foreign parent. All lobbying efforts, while not controlled, supervised, or directed by the parent, benefit the parent tangentially.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN BURRELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.